Featured Posts
Misuse of Bayh-Dole March-In Rights Would Stunt Medical Innovation, Threaten American Competitiveness
In March, the Biden Administration’s U.S. Department of Health and Human Services (HHS) and the Department of Commerce (DOC) announced a Working Group to…
Commentary
IRA Drug Price Controls Hearing Provides Valuable Insight on Policy’s Negative Effects
Last week, the Oversight and Investigations Subcommittee of the House Energy & Commerce Committee had a hearing titled “At What Cost: Oversight of How the…
Commentary
ATR Supports Bills to Expand Health Savings Accounts
Today, the Ways and Means Committee will hold a markup on H.R. 5688, the Bipartisan HSA Improvement Act of 2023 and H.R. 5687, the…
Commentary
Filtered Posts
CBO: Dem Healthcare Policies Will Kick Millions of their Healthcare Plans, Increase Deficit
Commentary
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Study: Democrats’ $3.5 Trillion Bill Will Lead to Up To 324 Fewer New Medicines
Commentary